Clinical Trial Update: KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure [NA]

View source ↗

Summary

Clinical trial update: KiteLock 4% EDTA Lock Solution is being studied to prevent occlusions in children with intestinal failure; the trial is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Failure

Drugs mentioned

• KiteLock 4% EDTA Lock Solution (ethylenediaminetetraacetic acid (EDTA) lock solution)

Snippet

Sponsor: SterileCare Inc. | Conditions: Pediatric Intestinal Failure | NA | Status: RECRUITING